Latest Market Speculation News

Codeifai Limited has addressed ASX concerns over unusual trading activity, confirming awareness of undisclosed information and releasing a status update on proposed transactions.

REA Group has confirmed it is under investigation by the ACCC concerning its subscription offerings, signaling potential regulatory scrutiny for the property tech giant.

Wellnex Life Limited’s shares have been suspended from trading on the ASX pending a response to regulatory queries, stirring investor uncertainty.

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.

Mayne Pharma has voluntarily withdrawn a speaker presentation for its contraceptive NEXTSTELLIS® following an FDA Untitled Letter concerning promotional claims. The company confirms this does not impact sales or its planned merger with Cosette.

Mayne Pharma has addressed a sharp share price decline following the public release of an FDA Untitled Letter, confirming no undisclosed material information and reaffirming compliance with ASX rules.

Holista Colltech Limited has responded to an ASX price query regarding recent unusual trading activity, confirming no undisclosed material information exists to explain the surge.

Botanix Pharmaceuticals has clarified that recent share price movements are linked to a rumored US executive order on drug pricing, confirming no undisclosed material information. The company reassures investors of compliance with ASX disclosure rules amid market speculation.

PointsBet Holdings has signaled openness to a new acquisition offer from Betr Entertainment, proposing mutual due diligence to explore potential synergies and share value. The board remains committed to the existing MIXI scheme unless a superior proposal emerges.

BrainChip Holdings Ltd’s 2025 AGM reveals a strengthened product roadmap, breakthrough Edge AI technology advances, and a surge in commercial partnerships, positioning the company for accelerated growth.

Spenda Limited has responded to an ASX price query following a notable rise in its share price and trading volume, denying any undisclosed material information while confirming ongoing confidential negotiations for virtual card and funding services.

Kingsgate Consolidated Limited has announced an on-market share buy-back as part of its capital management strategy, signaling confidence amid current market conditions.